237 related articles for article (PubMed ID: 30547906)
1. Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up.
Bianchi L; Gandaglia G; Fossati N; Larcher A; Pultrone C; Turri F; Selli C; de Groote R; de Naeyer G; Borghesi M; Schiavina R; Brunocilla E; Briganti A; Montorsi F; Mottrie A
Minerva Urol Nefrol; 2019 Feb; 71(1):38-46. PubMed ID: 30547906
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
4. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
[TBL] [Abstract][Full Text] [Related]
5. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
[TBL] [Abstract][Full Text] [Related]
6. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.
Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
Eur Urol Focus; 2018 Apr; 4(3):351-359. PubMed ID: 28753802
[TBL] [Abstract][Full Text] [Related]
7. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
8. Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
Sukumar S; Rogers CG; Trinh QD; Sammon J; Sood A; Stricker H; Peabody JO; Menon M; Diaz-Insua M
BJU Int; 2014 Dec; 114(6):824-31. PubMed ID: 24053586
[TBL] [Abstract][Full Text] [Related]
9. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy.
García-Barreras S; Rozet F; Nunes-Silva I; Srougi V; Sanchez-Salas R; Barret E; Galiano M; Cathelineau X
Clin Transl Oncol; 2018 Aug; 20(8):1004-1010. PubMed ID: 29243074
[TBL] [Abstract][Full Text] [Related]
11. Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years.
Suardi N; Ficarra V; Willemsen P; De Wil P; Gallina A; De Naeyer G; Schatteman P; Montorsi F; Carpentier P; Mottrie A
Urology; 2012 Jan; 79(1):133-8. PubMed ID: 22088567
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer.
Lee D; Choi SK; Park J; Shim M; Kim A; Lee S; Song C; Ahn H
Korean J Urol; 2015 Aug; 56(8):572-9. PubMed ID: 26279826
[TBL] [Abstract][Full Text] [Related]
13. Patterns of positive surgical margins after open radical prostatectomy and their association with clinical recurrence.
Bianchi L; Schiavina R; Borghesi M; Casablanca C; Chessa F; Mineo Bianchi F; Pultrone C; Vagnoni V; Ercolino A; Dababneh H; Fiorentino M; Brunocilla E
Minerva Urol Nefrol; 2020 Aug; 72(4):464-473. PubMed ID: 31144486
[TBL] [Abstract][Full Text] [Related]
14. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
16. Safety of robot-assisted radical prostatectomy in an Italian spoke hospital: Long-term oncologic and functional outcomes with median 11.3 years follow-up.
Fulcoli V; Bianco M; Sartor G; Agostini A; Costa G; Laurini L
Urologia; 2022 May; 89(2):248-256. PubMed ID: 35139712
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification for disease progression in pT3 prostate cancer after robot-assisted radical prostatectomy.
Hong JH; Kwon YS; Kim IY
Asian J Androl; 2017; 19(6):700-706. PubMed ID: 28230003
[TBL] [Abstract][Full Text] [Related]
18. Biochemical outcomes after robot-assisted radical prostatectomy in patients with follow-up more than 5-years.
Kim KH; Lim SK; Shin TY; Chung BH; Hong SJ; Rha KH
Asian J Androl; 2013 May; 15(3):404-8. PubMed ID: 23524532
[TBL] [Abstract][Full Text] [Related]
19. Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Bates AS; Mouraviev V; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Jun; 11(2):129-138. PubMed ID: 27435701
[TBL] [Abstract][Full Text] [Related]
20. Five-year Outcomes for a Prospective Randomised Controlled Trial Comparing Laparoscopic and Robot-assisted Radical Prostatectomy.
Porpiglia F; Fiori C; Bertolo R; Manfredi M; Mele F; Checcucci E; De Luca S; Passera R; Scarpa RM
Eur Urol Focus; 2018 Jan; 4(1):80-86. PubMed ID: 28753822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
